Placental characteristics in women with polycystic ovary syndrome

Human Reproduction

Volumn 30, Issue 12, 2015, Pages 2829-2837

  Koster, Maria P H ^a   DeWilde, Marlieke A ^a   Veltman Verhulst, Susanne M ^a   Houben, Michiel L ^a   Nikkels, Peter G J ^a   Van Rijn, Bas B ^a,b   Fauser, Bart C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Histology; Microscopic; Placenta; Polycystic ovary syndrome; Pregnancy complications

Indexed keywords

ADULT; ARTICLE; CESAREAN SECTION; CHORIOAMNIONITIS; COHORT ANALYSIS; CONCEPTION; CONTROLLED STUDY; DELIVERY; ERYTHROCYTE; FEMALE; FUNISITIS; HUMAN; IMMATURITY; INFARCTION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OVARY POLYCYSTIC DISEASE; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSPECTIVE STUDY; THROMBOSIS; ANOXIA; PATHOLOGY;

ADULT; ANOXIA; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PLACENTA; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 84983167715     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev265     Document Type: Article

References (39)

1. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-683.
2. Challier JC, Basu S, Bintein T, Minium J, Hotmire K, Catalano PM, Hauguel-de Mouzon S. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008;29:274-281.
3. Daskalakis G, Marinopoulos S, Krielesi V, Papapanagiotou A, Papantoniou N, Mesogitis S, Antsaklis A. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol Scand 2008;87:403-407.
4. de LaatMW, van der Meij JJ, Visser GH, Franx A, Nikkels PG. Hypercoiling of the umbilical cord and placental maturation defect: associated pathology? Pediatr Dev Pathol 2007;10:293-299.
5. de Wilde MA, Veltman-Verhulst SM, Goverde AJ, Lambalk CB, Laven JS, Franx A, Koster MP, Eijkemans MJ, Fauser BC. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome. Hum Reprod 2014;29:1327-1336.
6. Denison FC, Roberts KA, Barr SM, Norman JE. Obesity, pregnancy, inflammation, and vascular function. Reproduction 2010;140:373-385.
7. Evers IM, Nikkels PG, Sikkema JM, Visser GH. Placental pathology in women with type 1 diabetes and in a control group with normal and largefor-gestational-age infants. Placenta 2003;24:819-825.
8. Fauser BC, Tarlatzis BC, RebarRW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97:28-38. e25.
9. Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed accorDing to the Rotterdam consensus criteria. HumReprod 2009;24:710-717.
10. Higgins MF, Russell NM, Mooney EE, McAuliffe FM. Clinical and ultrasound features of placental maturation in pre-gestational diabetic pregnancy. Early Hum Dev 2012;88:817-821.
11. Houben ML, Nikkels PG, van Bleek GM, Visser GH, RoversMM, Kessel H, de Waal WJ, Schuijff L, Evers A, Kimpen JL et al. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 2009;4:e6572.
12. Huang L, Liu J, Feng L, Chen Y, Zhang J, Wang W. Maternal prepregnancy obesity is associated with higher risk of placental pathological lesions. Placenta 2014;35:563-569.
13. Jeve YB, Konje JC, Doshani A. Placental dysfunction in obese women and antenatal surveillance strategies. Best Pract Res Clin Obstet Gynaecol 2014; 3:350-364.
14. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011; 204:558-558.
15. Korst LM, Phelan JP, Ahn MO, Martin GI. Nucleated red blood cells: an update on the marker for fetal asphyxia. Am J Obstet Gynecol 1996; 175:843-846.
16. Laurini RN, Visser GH, van Ballegooie E, Schoots CJ. Morphological findings in placentae of insulin-dependent diabetic patients treated with continuous subcutaneous insulin infusion (CSII). Placenta 1987;8:153-165.
17. Longtine MS, Nelson DM. Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition. Semin Reprod Med 2011;29:187-196.
18. Madazli R, Tuten A, Calay Z, Uzun H, Uludag S, Ocak V. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls. Gynecol Obstet Invest 2008; 65:227-232.
19. Mrizak I, Grissa O, Henault B, Fekih M, Bouslema A, Boumaiza I, Zaouali M, Tabka Z, Khan NA. Placental infiltration of inflammatory markers in gestational diabetic women. Gen Physiol Biophys 2014;33:169-176.
20. Palomba S, Russo T, Falbo A, Di Cello A, Amendola G, Mazza R, Tolino A, Zullo F, Tucci L, La Sala GB. Decidual endovascular trophoblast invasion in women with polycystic ovary syndrome: an experimental case-control study. J Clin Endocrinol Metab 2012;97:2441-2449.
21. Palomba S, Russo T, Falbo A, Di Cello A, Tolino A, Tucci L, La Sala GB, Zullo F. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome. Hum Reprod 2013;28:2838-2847.
22. Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 2015;5:575-592.
23. Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, ChenHY. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2013;11:56.
24. Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta 2008;29 Suppl A:S86-S91.
25. Redman CW, Sargent IL. Latest advances in understanDing preeclampsia. Science 2005;308:1592-1594.
26. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related topolycysticovary syndrome(PCOS). HumReprod2004;19:41-47.
27. Salafia CM, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989;73:383-389.
28. Salafia CM, Pezzullo JC, Lopez-Zeno JA, Simmens S, Minior VK, Vintzileos AM. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol 1995;173:1097-1105.
29. Schokker DF, Visscher TL, Nooyens AC, van Baak MA, Seidell JC. Prevalence of overweight and obesity in the Netherlands. Obes Rev 2007;8:101-108.
30. Sikkema JM, Franx A, BruinseHW, van derWijkNG, deValkHW, NikkelsPG. Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia. Placenta 2002; 23:337-342.
31. Staff AC, Johnsen GM, Dechend R, Redman CW. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 2014;101-102:120-126.
32. Stallmach T, Hebisch G, Meier K, Dudenhausen JW, Vogel M. Rescue by birth: defective placental maturation and late fetal mortality. Obstet Gynecol 2001;97:505-509.
33. Sun M, Maliqueo M, Benrick A, Johansson J, Shao R, Hou L, Jansson T, WuX, Stener-Victorin E. Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring. Am J Physiol Endocrinol Metab 2012;303:E1373-E1385.
34. Veerbeek JH, Nikkels PG, Torrance HL, Gravesteijn J, Post Uiterweer ED, Derks JB, Koenen SV, Visser GH, Van Rijn BB, Franx A. Placental pathology in early intrauterine growth restriction associated with maternal hypertension. Placenta 2014;35:696-701.
35. Veltman-Verhulst SM, Fauser BC, Eijkemans MJ. High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice. Fertil Steril 2012;98:761-768. e1.
36. Visser N, van Rijn BB, Rijkers GT, Franx A, Bruinse HW. Inflammatory changes in preeclampsia: current understanDing of the maternal innate and adaptive immune response. Obstet Gynecol Surv 2007; 62:191-201.
37. Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM. NewDutch reference curves for birthweight by gestational age. Early Hum Dev 2009; 85:737-744.
38. World Health Organization. Nutrition, Physical Activity and Obesity: Netherlands 2013;2013:5.
39. Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity upregulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010; 31:387-391.